Oxidation affects the flow-induced aggregation of low density lipoprotein and its inhibition by albumin

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1634, Issue 1-2, 2003, Pages 24-29

  Talbot, Roy M ^a   Del Rio, Jessica D ^a   Leake, David S ^a   Weinberg, Peter D ^a  

^a UNIVERSITY OF READING   (United Kingdom)

Author keywords

Aggregation; Albumin; Flow; Low density lipoprotein; Oxidation; Vortexing

Indexed keywords

ALBUMIN; LIPID HYDROPEROXIDE; LOW DENSITY LIPOPROTEIN;

ARTICLE; BLOOD; ELECTROPHORETIC MOBILITY; HUMAN; INCUBATION TIME; OXIDATION; PRIORITY JOURNAL; PROTEIN AGGREGATION;

EID: 0141918806     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbalip.2003.08.002     Document Type: Article

References (45)

1. Kruth H.S. Localization of unesterified cholesterol in human atherosclerotic lesions: demonstration of filipin-positive, Oil-Red-O-negative particles. Am. J. Pathol. 114:1984;201-208.
2. Simionescu N., Vasile E., Lupu F., Popescu G., Simionescu M. Prelesional events in atherogenesis. Accumulation of extracellular cholesterol-rich liposomes in the arterial intima and cardiac valves of the hyperlipidemic rabbit. Am. J. Pathol. 123:1986;109-125.
3. Frank J.S., Fogelman A.M. Ultrastructure of the intima in WHHL and cholesterol-fed rabbit aortas prepared by ultra-rapid freezing and freeze-etching. J. Lipid Res. 30:1989;967-978.
4. Guyton J.R., Klemp K.F., Black B.L., Bocan T.M. Extracellular lipid deposition in atherosclerosis. Eur. Heart J. 11:1990;20-28. (Suppl.).
5. Steinbrecher U.P., Lougheed M. Scavenger receptor-independent stimulation of cholesterol esterification in macrophages by low density lipoprotein extracted from human aortic intima. Arterioscler. Thromb. 12:1992;608-625.
6. Tirzu D., Dobrian A., Tasca C., Simionescu M., Simionescu N. Intimal thickenings of human aorta contain modified reassembled lipoproteins. Atherosclerosis. 112:1995;101-114.
7. Khoo J.C., Miller E., McLoughlin P., Steinberg D. Enhanced macrophage uptake of low density lipoprotein after self-aggregation. Atherosclerosis. 8:1988;348-358.
8. Suits A.G., Chait A., Aviram M., Heinecke J.W. Phagocytosis of aggregated lipoprotein by macrophages: low density lipoprotein receptor-dependent foam-cell formation. Proc. Natl. Acad. Sci. U. S. A. 86:1989;2717-2731.
9. Heinecke J.W., Suits A.G., Aviram M., Chait A. Phagocytosis of lipase-aggregated low density lipoprotein promotes macrophage foam cell formation. Arterioscler. Thromb. 11:1991;1643-1651.
10. Xu X.X., Tabas I. Sphingomyelinase enhances low-density-lipoprotein uptake and ability to induce cholesteryl ester accumulation in macrophages. J. Biol. Chem. 266:1991;24849-24858.
11. Aviram M. Modified forms of low density lipoprotein and atherosclerosis. Atherosclerosis. 98:1993;1-9.
12. Margolis S. Separation and size determination of human serum lipoproteins by agarose gel filtration. J. Lipid Res. 8:1967;501-507.
13. Kovanen P.T., Kokkonen J.O. Modification of low density lipoprotein by secretory granules of rat serosal mast cells. J. Biol. Chem. 266:1991;4430-4436.
14. Piha M., Lindsteldt L., Kovanen P.T. Fusion of proteolysed low density lipoprotein in the fluid phase: a novel mechanism generating atherogenic lipoprotein particles. Biochemistry. 34:1995;10120-10129.
15. Pentikäinen M.O., Lehtonen E.M.P., Kovanen P.T. Aggregation and fusion of modified low density lipoprotein. J. Lipid Res. 37:1996;2638-2649.
16. Tertov V.V., Sobenin I.A., Gabbasov Z.A., Popov E.G., Orekhov A.N. Lipoprotein aggregation as an essential condition of intracellular lipid accumulation caused by modified low density lipoproteins. Biochem. Biophys. Res. Commun. 163:1989;489-494.
17. Hoff H.F., O'Neil J. Lesion-derived low density lipoprotein and oxidised low density lipoprotein share a lability for aggregation, leading to enhanced macrophage degradation. Arterioscler. Thromb. 11:1991;1209-1222.
18. Dobrian A., Mora R., Simionescu M., Simionescu N. In vitro formation of oxidatively-modified and reassembled low density lipoproteins: antioxidant effect of albumin. Biochim. Biophys. Acta. 1169:1993;12-24.
19. Kawabe Y., Cynshi O., Takashima Y., Suzuki T., Ohba Y., Kodama T. Oxidation-induced aggregation of rabbit low-density lipoprotein by azo initiator. Arch. Biochem. Biophys. 310:1994;489-496.
20. Hazell L.J., Van Den Berg J.J.M., Stocker R. Oxidation of low-density lipoprotein by hypochlorite causes aggregation that is mediated by modification of lysine residues rather than lipid oxidation. Biochem. J. 302:1994;297-304.
21. 2+-induced oxidation. Biochem. J. 310:1995;417-426.
22. Hunter J.A., Shahrokh Z., Forte T.M., Nichols A.V. Aggregation of low density lipoproteins with unilamellar phosphatidylcholine vesicles. Biochem. Biophys. Res. Commun. 105:1982;828-834.
23. Arnold K., Zschörnig O. Aggregation of human low density lipoprotein by means of poly(ethylene glycol). Biomed. Biochim. Acta. 47:1988;949-954.
24. Rankin S.M., De-Whalley C.V., Hoult J.R.S., Jessup W., Wilkins G.M., Collard J., Leake D.S. The modification of low density lipoprotein by the flavonoids myricetin and gossypetin. Biochem. Pharmacol. 45:1993;67-75.
25. Khoo J.C., Miller E., McLoughlin P., Steinberg D. Prevention of low density lipoprotein aggregation by high density lipoprotein or apolipoprotein A-1. J. Lipid Res. 31:1990;645-652.
26. Talbot R.M., del Rio J.D., Weinberg P.D. Effect of fluid mechanical stresses and plasma constituents on aggregation of low density lipoprotein. J. Lipid Res. 2003 (Jan. 16);. (epub ahead of print: http://www.jlr.org/cgi/reprint/M200477-JLR200v1.pdf ).
27. Wilkins G.M., Leake D.S. The effect of inhibitors of free radical generating-enzymes on low density lipoprotein oxidation by macrophages. Biochim. Biophys. Acta. 1221:1994;69-78.
28. Schacterle G.R., Pollack R.L. A simplified method for the quantitative assay of small amounts of protein in biological material. Anal. Biochem. 51:1973;654-655.
29. Rice-Evans C., Leake D.S., Bruckdorfer K.R., Diplock A.T. Practical approaches to low density lipoprotein oxidation: whys, wherefores and pitfalls. Free Radic. Res. 25:1996;285-311.
30. Siow R.C.M., Richards J.P., Pedley K.C., Leake D.S., Mann G.E. Vitamin C protects human vascular smooth muscle cells against apoptosis induced by moderately oxidized LDL containing high levels of lipid hydroperoxides. Arterioscler. Thromb. Vasc. Biol. 19:1999;2387-2394.
31. El-Saadani M., Esterbauer H., El-Sayed M., Goher M., Nasser A.Y., Jürgens G. A spectrophotometric assay for lipid peroxides in serum lipoproteins using a commercially available reagent. J. Lipid Res. 30:1989;627-630.
32. Armitage P., Berry G. Statistical Methods in Medical Research. 2nd ed. 1987;Blackwell, Oxford.
33. Ray B.R., Davisson E.O., Crespi H.L. Experiments on the degradation of lipoproteins from serum. J. Phys. Chem. 58:1954;841-846.
34. Schuh J., Fairclough G.F., Haschemeyer R.H. Oxygen-mediated heterogeneity of apo-low density lipoprotein. Proc. Natl. Acad. Sci. U. S. A. 75:1978;3173-3177.
35. Berliner J.A., Territo M.C., Sevanian A., Ramin S., Kim J.A., Bamshad B., Eterson M., Fogelman A.M. Minimally modified low density lipoprotein stimulates monocytes endothelial interactions. J. Clin. Invest. 85:1990;1260-1266.
36. Henriksen T., Mahoney E.M., Steinberg D. Enhanced macrophage degradation of biologically modified low density lipoprotein. Arteriosclerosis. 3:1983;149-159.
37. Hurt-Camejo E., Camejo G., Rosengren B., Lopez F., Ahlstrom C., Fager G., Bondjers G. Effect of arterial proteoglycans and glycosaminoglycans on low density lipoprotein oxidation and its uptake by human macrophages and arterial smooth muscle cells. Arterioscler. Thromb. 12:1992;569-583.
38. Fong L.G., Parthasarathy S., Witztum J.L., Steinberg D. Nonenzymic oxidative cleavage of peptide bonds in apoprotein B-100. J. Lipid Res. 28:1987;1466-1477.
39. Herak J.N. Physical changes of low-density lipoprotein on oxidation. Chem. Phys. Lipids. 66:1993;231-234.
40. Ramalingam K., Bello J. Conformational and aggregational states of ω-aminoacylmelittin derivatives. Biochemistry. 32:1993;253-259.
41. Palinski W., Ylä-Hertualla S., Rosenfeld M.E., Butler S.W., Socher S.A., Parthasarathy S., Curtiss L.K., Witztum J.L. Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein. Arteriosclerosis. 10:1990;325-335.
42. Parums D.V., Brown D.L., Mitchinson M.J. Serum antibodies to oxidized low-density lipoprotein and ceroid in chronic periaortitis. Arch. Pathol. Lab. Med. 114:1990;383-387.
43. Javed Q., Leake D.S., Weinberg P.D. Quantitative immunohistochemical detection of oxidized low density lipoprotein in the rabbit arterial wall. Exp. Mol. Pathol. 65:1999;121-140.
44. Maor I., Hayek T., Coleman R., Aviram A. Plasma LDL oxidation leads to its aggregation in the atherosclerotic apolipoprotein E-deficient mouse. Arterioscler. Thromb. Vasc. Biol. 17:1997;2995-3005.
45. Aviram M. Plasma lipoprotein separation by discontinuous density gradient ultracentrifugation in hyperlipoproteinemic patients. Biochem. Med. 30:1983;111-118.